Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 4 1

Status

Recruiting 9Unknown 8Active not recruiting 4Terminated 3Not yet recruiting 3Completed 3Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 2Breast 1

Conditions

Paraproteinemias 2Immunoglobulin Light-chain Amyloidosis 2Papillomavirus Infections 1Intermittent Fasting 1Breast Neoplasms 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Clinical Protocols × Clear all
NCT04206813 2026-04-29

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Boston Medical Center

Phase 4 Active not recruiting
352 enrolled

Papillomavirus Infections

NCT04512235 2026-04-07

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

Alexion Pharmaceuticals, Inc.

Phase 3 Active not recruiting
281 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Paraproteinemias

NCT04504825 2026-03-17

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)

Alexion Pharmaceuticals, Inc.

Phase 3 Active not recruiting
125 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Paraproteinemias

NCT07440784 2026-02-27

Impact Of Intermittent And Water-Only Fasting On Gene Expression And Tumor Markers In Breast Cancer

Khyber Medical University Peshawar

Phase NA Active not recruiting
60 enrolled
Breast

Intermittent Fasting, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡